International Journal of Drug Policy

Article	Citations
Publisher's Note	248
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	167
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	94
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	82
A matter of craving–An archeology of relapse prevention in Swedish addiction treatment	75
Editorial Board	63
Editorial Board	61
Editorial Board	58
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	57
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	54
Editorial Board	54
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	53
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	51
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	48
A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024	48
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	48
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	47
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	47
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	46
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	45
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	45
Ecological dimensions of cannabis regulation in the Rif, Morocco	44
Editorial Board	44
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	43
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	42

Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	41
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	40
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	39
A content analysis of cannabis edibles package marketing in the United States	39
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial	38
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	38
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia	38
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	38
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020	37
Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky	36
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	35
Putting tendencies and trajectories to work: useful tools for engaging with accounts of change and recovery?	35
Cannabis reduction among adolescents as spillover from successful tobacco control	35
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis	35
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities	34
Speed and smoking kill: A time-varying survival analysis linking methamphetamine use, cigarette smoking, and mortality in sexual minority men	34
Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010–2021	34
Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans	34
Transnational alcohol corporations in Nigeria as commercial determinants of health: Implications for policy	34
Societal costs of illegal drug use in Sweden	33
Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use	32
The hammer and the nail: The triple lock of methods, realities and institutional contexts in Australian research on nightlife violence	32
The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study	32
How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experi	32
‘As for dignity and respect…. me bollix’: A human rights-based exploration of service user narratives in Irish methadone maintenance treatment	31
Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis	31
A readiness assessment for the prevention of alcohol-related harm in West Africa: A new methodological approach to inform practice and policy	30
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic	30
Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use	30
Stronger isn’t always better: Nalmefene in community overdose response and the false promise of quick-fix public health solutions	30
Ethical justifications for safe supply interventions	30
Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB	29
Does diverting minor drug offenders reduce recidivism? Cannabis cautioning in Australia	29
Parenting and heavy substance use: From neutralization theory to actor-network theory to avoid stigmatizing participants	29
Quantitative controls on the number and/or location of alcohol retail outlets: an overview of approaches in the USA and Canada	28
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	28
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK	27
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	27
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington	27
Global cannabis cultivation as a gendered activity: Findings from the 2020 International Cannabis Cultivation Questionnaire	27
Drug transactions and the dark web: Public perceptions of the locational setting of offenders and support for drug policy outcomes	27
Trends in young people accessing English alcohol treatment services: 2014 to 2023	26
Measuring drug policy evolution: A cross-country analysis	26
“What I should be doing is harm reduction, if I'm doing my job right”: Engagement with harm reduction principles among prosecutors enacting drug policy reform in the United States	26
Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia	26
Reluctant risk-takers: how law enforcement practices at festivals can obstruct safer drug use	26
An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries	26
Growing pains: A study of administrative burden and regulatory compliance in German Cannabis Cultivation Associations under the Cannabis Act	25
COVID-19 economic impact payments and opioid overdose deaths	25
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022	25

Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?	25
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine	25
From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems	25
High levels of all-cause mortality among people who inject drugs from 2018 to 2022	25
Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods	24
Vaccination coverage among people who inject drugs: A systematic review	24
Becoming a nitrous oxide user on social media: Learning to maximise pleasures and minimise harms	24
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	24
Consent and violence amongst men in the context of sexualised drug use: A systematic scoping review	24
Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK	24
Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia	24
Tackling the overdose crisis through unionization: A response to Rivera & Friedman (2024)	23
Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior	23
Intersecting stigmas: How racial attitudes shape support for treatment and harm reduction for people who inject drugs	23
2S/LGBTQ+ youth substance use and pathways to homelessness: A photovoice study	23
Editorial Board	23
Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks	23
Editorial Board	23
Slamsex as slow edgework: Sexualized drug use and harm reduction in post-AIDS Taiwan	23
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people	22
Municipal socioeconomic environment and recreational cannabis use in Mexico: Analysis of two nationally representative surveys	22
Countering the institutionalization of harm reduction through critical pragmatism	22
Exploring the need for overdose prevention centers in England: A qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments	22
Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary	22
The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study	22
Editorial Board	21
Problematizing “patient stability” in opioid use disorder care: Flexible definitions, (in)flexible treatment	21
“Harm per litre” as a concept and a measure in studying determinants of relations between alcohol consumption and harm	21
Aging and street capital: Older men’s status and strategies in street culture	21
Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan	21
Minimum legal age laws and perceived access to cigarettes, e-cigarettes, and other substances among youth in Canada, England, and the United States: 2017-2021	21
The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives	21
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study	21
Public support for reinvesting resources from enforcing drug possession to health-promoting alternatives: A nationally representative poll of adults in the United States	21
The impact of alcohol minimum unit pricing on people with experience of homelessness: Qualitative study	20
Naloxone cascade of care among people who regularly inject drugs in Australia, 2020–2022	20
Interconnected influence: Unraveling purdue pharmaceutical's role in the global response to the opioid crisis	20
Standard THC units: A tool to benchmark cannabis-related driving risks	20
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study	19
Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021	19
The success rate of online illicit drug transactions during a global pandemic	19
Drug use typology, demographic covariates, and associations with condomless anal sex: A latent class analysis among a U.S. national cohort of men who have sex with men	19
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes	19
Pre-implementation findings on the barriers and potential solutions to initiate same-day antiretroviral therapy among people who inject drugs in Malaysia	19
Psychedelic discourses: A qualitative study of discussions in a Danish online forum	19
Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis	19
Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study	19
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	19
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement	19
The intersection of substance use stigma and anti-Black racial stigma: A scoping review	19
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis	19
Drugs, guns, and violent crime in California	19
Characterizing changes in drug use behaviour following supply shortages of 5-MeO-DIPT, alkyl nitrites and new psychoactive substances among men living with HIV in Japan	18
“It’s not just the hit itself”: the social practice of injecting drug use among gay and bisexual men in Australia	18
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada	18
Risky alcohol use and violence against women: cause or consequence?	18
Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia	18
Current regulations in context: Scraping Australia's online nitrous oxide market	18
Editorial Board	18
Post-retirement enlightenment syndrome: Worthy of investigation	18
Transitions to legal cannabis markets: Legal market capture of cannabis expenditures in Canada following federal cannabis legalization	18
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19	17
Beverage-specific consumption trends: A cross-country, cross-sectional comparison	17
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia	17
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey	17
‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK	17
The association between social capital and drug overdose mortality in the United States	17
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today	17
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019	17
Decline in youth drinking in high-income settings: Implications for public health in low-income countries	17
Editorial Board	17
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit	17
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study	17
Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange	16
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study	16
Editorial - Supporting the best quality science and the rights of people who use drugs regardless of global policy changes: Perspectives from the co-Editors in Chief of the International Journal of Dr	16
Exploring how an e-cigarette intervention influenced tobacco smoking behaviour in people accessing homelessness services: Findings from the SCeTCH trial process evaluation	16
Through the wine glass: How biographical midlife transitions and women's affective interpretations interact with alcohol consumption	16
Corrigendum to “Sociological investigations of human enhancement drugs: The case of microdosing psychedelics” [International Journal of Drug Policy 95 (2021) 103099]	16
Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011	16

Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids	16
A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova	16
Corrigendum to ‘Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)’ [Volume 114, April	16
Neutral attitude toward the utilization of psychedelic therapy for depression in the United Kingdom population	16
Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey	16
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study	16
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	15
Dublin’s supervised injecting facility: An assessment of its impact on discarded needles	15
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops	15
Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California	15
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study	15
Anti-doping measures in gyms and fitness centres: A mapping of practices in the state parties of the council of Europe’s anti-doping convention	15
Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility	15
Recovery as a minor practice	15
Scoping review of the characteristics and implementation of routine outcome monitoring and feedback for adults and young people accessing alcohol and other drug use treatment	15
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022	15
Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020	15
Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine	15
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial	15
A call for compassionate opioid overdose response	15
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	14
Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward	14
Disentangling opioids-related overdose syndemics: a scoping review	14
Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah	14
“I've lost my children to vaping”: A frame analysis of the Australian media's construction of the “Youth vaping crisis”	14
“It should be hard to be a drug abuser” An evaluation of the criminalization of drug use in Sweden	14
‘Some days I am a lunatic that thinks I can moderate’: Amalgamating recovery and neo-liberal discourses within accounts of non-drinking among women active in the ‘positive sobriety’ community on Insta	14
Changing Trends in Nonmedical Gabapentin Use Among a Cohort of Rural Appalachian People Who Use Drugs: A Longitudinal Study Over the Time Period of Scheduling Changes in Kentucky	14
Unpacking the differing understandings of “alcohol industry” in public health research	14
Volatile substances are an amorphous category, making it hard to build a comprehensive body of research	14
Community-administered naloxone for overdose reversal: The role of sex worker-led programming and occupational violence in a community-based cohort (2018–2024)	14
“There’s a lot of stereotypes going on”: A cross-national qualitative analysis of the place of gender in declining youth drinking	14
‘I just drink to feel abnormal for some time’: Reconfiguring heavy drinking and intoxication as pleasurable	14
Drug policy goals in a changing landscape: Perspectives of practitioners in Japan	14
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas	14
The economic factors that determine smoking abstinence: a survival and mediation analysis	14
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses	14
Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)	14
Stimulant-involved overdose deaths: Constructing dynamic hypotheses	13
From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport	13
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study	13
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners	13
Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada	13
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020	13
Multilevel determinants of cannabis prices in legal markets: Evidence from products sold in nearly 4000 cannabis dispensaries in the United States	13
Are dietary supplement users more likely to dope than non-users?: A systematic review and meta-analysis	13
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada	13
The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians	13
Public calls for service to the police: Trends before and during drug possession decriminalization in Oregon	13
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study	13
Editorial Board	13
The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment	13
Psychomodulatory substances: New legislative framework for control of psychoactive substances in Czechia	13
Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme	13
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality	13
Implementation of a multi-component alcohol policy in Ireland: A qualitative study exploring barriers and facilitators to implementation	13
Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada	13
Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020	13
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study	13
Like birds of a feather? A multi-case study on the connections between cannabis, tobacco, alcohol and pharmaceutical companies in legalized cannabis markets	13
Where to next? An exploration of ‘night-out’ location progression and propensity to experience violence in night -time entertainment precincts	13
Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review	12
Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services	12
Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal pos	12
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches	12
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	12
A concept mapping study of service user design of safer supply as an alternative to the illicit drug market	12
Factors associated with attending “open bar” parties amongst early adolescents	12
Sex-specific trends in patterns of tobacco and nicotine use among young people in Denmark from 2020 to 2023: A multigroup latent class analysis	12
Understanding the longitudinal relationship between substance use and violent victimization among street-based women who exchange sex in Baltimore, Maryland	12
Unlocking deflection: The role of supervisor support in police officer willingness to refer people who inject drugs to harm reduction services	12
Safer supply programs: Discussions on medication diversion, sharing, and selling	12
“Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program	12
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue	12
Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic	12
Editorial Board	11
Social forces shaping evidence production: A study of the swiss cannabis pilot trials	11
The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol	11
Reduction in substance use stigma following a peer-recovery specialist behavioral activation intervention	11
Effective package warning label systems for communicating relative risks of cigarettes, heated tobacco products, and e-cigarettes: An experimental study with Korean adults	11
Trends and correlates of naloxone possession and use among people who inject drugs in Seattle, Washington	11
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	11
Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk	11
Reimbursing incarcerated individuals for participation in research: A scoping review	11
Assessing options for cannabis law reform: A Multi-Criteria Decision Analysis (MCDA) with stakeholders in New Zealand	11
The ‘knowing’ body in the becoming of buprenorphine depot treatment: A qualitative study	11
“Another tool in the toolkit”—Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site	11
A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services	11
Programmatic alcohol advertising, social media and public health: Algorithms, automated challenges to regulation, and the failure of public oversight	11
What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland	11
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis	11
Barriers to calling emergency services amongst people who use substances in the event of overdose: A scoping review	11
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs	11
“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison	11
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: A national Delphi study	11